peptide 18 MLCK 억제제 펩타이드 18 - peptide-therapy-pasadena designed as a selective inhibitor of myosin light chain kinase (MLCK

peptide-therapy-protocols Peptide 18: A Multifaceted Molecule in Biological Research and Therapeutic Development

Peptide 18 emerges as a significant entity within the scientific community, primarily recognized for its role as a selective inhibitor of myosin light chain kinase (MLCK). This designation anchors its primary function: controlling the biological activity of MLCK, a crucial enzyme involved in various cellular processes. The high selectivity of MLCK inhibitor peptide 18, demonstrated by its potent inhibition of MLCK with an IC50 of 50 nM and a 4000-fold selectivity over CaM kinase II, underscores its precision as a research tool and potential therapeutic agentDevelopment and manufacture of synthetic peptides. Beyond its inhibitory capacity, peptide 18 also appears in contexts related to antimicrobial peptides, such as LL-37/hCAP-18, highlighting a broader spectrum of biological activities associated with peptides bearing the "18" designationMLCK inhibitor peptide 18is a myosin light chain kinase (MLCK) inhibitor with an IC50 of 50 nM, and inhibits CaM kinase II only at 4000-fold higher ....

Understanding MLCK Inhibitor Peptide 18

The most prominent manifestation of peptide 18 in scientific literature and product offerings is its function as a MLCK inhibitor peptide 18.Z'-LYTE™ Kinase Assay Kit - Ser/Thr18 Peptide; 產品號碼PV4319 ; 價格(TWD). 25,970.00. Online offer. Ends: 31-Dec-2025. 37,100.00. 您節省 11,130.00 (30%). Each. This peptide is a cell-permeable compound that precisely targets and inhibits myosin light chain kinase.MLCK inhibitor peptide 18 The enzyme MLCK plays a vital role in regulating smooth muscle contraction, cell motility, and other cellular functions through the phosphorylation of myosin light chains. By inhibiting MLCK, peptide 18 offers a valuable means to study these processes in vitro and in vivo. Its high selectivity is a critical attribute, ensuring that its effects are primarily directed at MLCK, minimizing off-target interactions and providing clearer experimental results. This precision makes it an indispensable tool for researchers investigating the downstream effects of MLCK activity, ranging from cellular signaling pathways to physiological responses.

Broader Applications and Research Avenues

While its role as an MLCK inhibitor is well-established, the "18" designation in peptide nomenclature appears in diverse research areas. For instance, Poly-Arginine Peptide-18 (R18) has shown promise in reducing brain injury and improving functional outcomes after stroke in preclinical models, suggesting neuroprotective capabilities. Furthermore, the human peptide antibiotic LL-37/hCAP-18 is recognized for its broad antimicrobial activity and its involvement in innate immunity, linking host defense with inflammation, angiogenesis, and wound healingMLCK inhibitor peptide 18 - MedChem Express. These examples illustrate that "peptide 18" can refer to distinct molecules with varied biological functions, necessitating careful identification based on context.MLCK inhibitor peptide 18 - Tocris Bioscience

The ongoing exploration of peptides in scientific research is further evidenced by advancements in 18 F-labeling of peptides, a technique crucial for developing radiopharmaceuticals for diagnostic imaging and targeted therapiesAntimicrobial Peptides PL-18, Initially developed by Protelight Pharmaceuticals, Now, its global highest R&D status is Phase 2, Therapeutic Areas: .... The development and manufacture of synthetic peptides, including those with specific numbering like peptide 18, are also areas of active innovation, aiming for enhanced purity, efficacy, and scalability.

Future Directions and Significance

The diverse roles of molecules designated as "peptide 18" highlight the intricate nature of peptide scienceMLCK inhibitor peptide 18. From precise enzyme inhibition with MLCK inhibitor peptide 18 to potential neuroprotection by Poly-Arginine Peptide-18 (R18) and the multifaceted antimicrobial and immunomodulatory functions of LL-37/hCAP-18, these peptides represent significant advancements in understanding and manipulating biological systemsMLCK inhibitor peptide 18is a selective competitive inhibitor of myosin light chain kinase (IC50 = 50 nM). Displays 4000-fold selectivity over CaM kinase II .... Continued research into these and other "peptide 18" entities promises to yield further insights into fundamental biological processes and drive the development of novel therapeutic strategies. The ability to precisely target cellular mechanisms, combat infections, and potentially mitigate neurological damage underscores the enduring importance of peptide research in the pursuit of improved human healthMLCK 억제제 펩타이드 18은 IC50이 50nM인 미오신 경쇄 키나제(MLCK) 억제제이며 4000배 더 높은 농도에서만 CaM 키나제 II를 억제합니다..